ArticleCancers2019

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma.

Mohammad Krayem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.